SCHEMBL3764641

SCHEMBL3764641

CC=CCOc1cccc(CN)c1F

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.39
RPS6KA1 Q15418 1/20 0.36
HTR2A P28223 2/20 0.34
MAOB P27338 2/20 0.33
HRH1 P35367 1/20 0.33
HTR1A P08908 1/20 0.33
CTSS P25774 3/20 0.33
CTSK P43235 3/20 0.33
CTSL P07711 2/20 0.33
CD274 Q9NZQ7 1/20 0.33
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
AOC3 Q16853 1/20 0.32
PNMT P11086 1/20 0.32
LTA4H P09960 1/20 0.31
PLA2G2A P14555 1/20 0.31
TRPM8 Q7Z2W7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3768083 0.86 TAAR1 (0.38) TAAR1RPS6KA1HTR2AMAOBHRH1
SCHEMBL3764835 0.84 RPS6KA1 (0.35) TAAR1RPS6KA1HTR2AMAOBMAPT
SCHEMBL3770868 0.83 L3MBTL1 (0.36) TAAR1RPS6KA1MAOBHRH1MAPT
SCHEMBL3769104 0.83 CTSS (0.39) TAAR1RPS6KA1MAOBHRH1CTSS
SCHEMBL3766281 0.82 L3MBTL1 (0.36) TAAR1RPS6KA1MAPTL3MBTL1
SCHEMBL12835858 0.81 CTSL (0.40) HTR1ACTSSCTSKCTSLMAPT
SCHEMBL1512481 0.81 CTSL (0.40) HTR1ACTSSCTSKCTSLMAPT
SCHEMBL3763441 0.81 CYSLTR2 (0.38) TAAR1RPS6KA1CTSSCTSKCTSL
SCHEMBL3770673 0.81 L3MBTL1 (0.35) TAAR1RPS6KA1MAPTL3MBTL1
SCHEMBL3766260 0.80 MAPT (0.49) HTR2AHTR1AMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHIEMCAL COMPANY LIMITED (JP) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME ATL3, NAT1, C5 TAAR1 773/4885RPS6KA1 1556/4885HTR2A 2559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.